Introduction
Nanomaterials with a size less than 100 nm are globally synthesized owing to their
various properties such as, antimicrobial, anti-inflammatory, wound healing,
catalytic, magnetic, optical, and electronic properties, that have put them at the
forefront of a wide variety of studies ( Gunalan
The introduction of nanoparticles in the consumer industry, health, food, space,
chemical, and cosmetics, has called for a green and environmentally responsible
strategy for their production ( Rao and Gautam,
2016). Metal oxides and dioxides such as zinc oxide, silver, gold and
titanium dioxide have received copious consideration because of their multiple
properties and applications ( Dobrucka and
Długaszewska, 2016). However, their synthesis has been done
through numerous physicochemical methods. Laser ablation, microwave irradiation and
vapour deposition have been reported to date ( Satyanarayana and Reddy, 2018), they involve forces of condensation,
dispersion, or fragmentation of bulk particles into nanoparticles, as well as some
toxic chemicals, harmful to the environment ( Dhandapani
Synthesis of nanomaterials through biological systems assisted by some
biotechnological tools is an emerging asset of nanotechnology that provides a safe,
cost-effective and eco-friendly synthesis process ( Shinwari and Maaza, 2017). Plants, diatoms, fungi, yeast,
algae, bacteria, and human cells have been used. Their proteins and other
metabolites have been well reported to have a reductive capacity that can transform
metal ions into metal nanoparticles ( Dobrucka and
Długaszewska, 2016; Parveen
Among all biological systems, phytosynthesis of nanoparticles using plants has shown
great potential. Plant-mediated nanoparticle synthesis is simple, eco-friendly, and
provides antibacterial assets ( Gunalan
Methods
Material
Leaves of bush tea (
Material preparation
Ten grams of ground bush tea leaves were weighed and mixed with 300 ml of deionized water. The mixture was heated at 60°C for 30 minutes until the water changed to a dark green colour. After centrifugation using a Hermle Labortecnik GmbH Z 216-M benchmark centrifuge at 4000 rpm for 10 minutes, the mixture was filtered twice using Whatman filter paper number 1, and the extract was kept in an airtight container in a fridge at ≈4°C for analysis and ZnO nanoparticles synthesis.
In this study, zinc nitrate hexahydrate [Zn (NO 3) 2.6H
2O] was used as the precursor. One gram of the precursor was
mixed with 25 ml of
The determination and profiling of different compounds present in the extract
before the synthesis as well as the supernatant after synthesis were performed
using liquid chromatography quadrupole time-of-flight mass spectrometry
(LC-Q-TOF-MS) using a Bruker impact II (Germany). After peak integration and
Pareto scaling, the liquid chromatography-mass spectrometry (LC-MS) data were
transformed into buckets using the Bruker Compass data analysis programme
version 4.3.110 ( https://www.bruker.com/en/). Peaks were determined using real
mass, MS/MS, and retention time (RT). The accuracy of the mass and MS/MS
spectral data was compared to the Kyoto standard Encyclopaedia of Genes and
Genomes (KEGG) and ChemSpider databases using the MetFrag 2.2
online software ( Tete
The characterization of the obtained ZnO nanopowders was done using X-ray
diffraction (XRD), Ultraviolet-visible spectroscopy (UV-Vis), Fourier-transform
infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and
energy-dispersive X-ray spectroscopy (EDS). The crystallite size of ZnO
nanoparticles was estimated using the modified Scherrer equation:
where
is the X-ray wavelength,
Results
Assessment of the synthesis process
The crude extract from bush tea leaves and the supernatant after the synthesis of
ZnO nanoparticles were investigated. The differences between the composition of
the crude extract and the supernatant after synthesis are represented in Figure 1. The results from the PCA
co-variance of data show that two distinct groups were observed from the three
principal components with 85.1%, 8.6% and 2.1% respectively for principal
components 1, 2 and 3. The compounds (represented in red) resulting from the
supernatant after synthesis of ZnO nanoparticles clustered together following
the Y-axis of the PCA while the compounds of crude extract were on the Z-axis.
The differences observed are due to the reaction between the plant extract and
the precursor to form ZnO nanoparticles. The synthesis of ZnO nanoparticles
involves a reaction between the plant extract and the precursor resulting in the
reduction of Zn +2 ions into ZnO nanoparticles ( Hussain
Figure 1.
Principal component analysis of liquid chromatography quadrupole
time-of-flight mass spectrometry (LC-Q-TOF-MS) peak intensities of 10
bush tea (
Figure 2 shows the different compound peaks
observed using LC-Q-TOF-MS analysis. The dissection of observed spectra into
compounds produced 100 different peaks for the crude extract ( Figure 2a) and 84 peaks for the supernatant
after synthesis ( Figure 2b). The reduction
in the number of compounds confirms that the synthesis took place and secondary
metabolites from
Figure 2.
Compound dissection (a) before the synthesis process (100 peaks) (b) after the synthesis process (84 peaks).
Different peaks identified, after chromatogram dissection ( Figure 2), from LC-Q-TOF-MS revealed the presence of several
compounds in both the crude extract and the supernatant after ZnO nanoparticle
synthesis, with a reduction of the compound’s amount in the supernatant
collected after synthesis. Thus, revealing the presence of an interaction
between the precursor and the extract mainly by the oxidation, reduction or
degradation of the phytochemical compounds that occur during nanoparticle
formation ( Jeevanandam
Table 1.
Liquid chromatography quadrupole time-of-flight mass spectrometry (LC-Q-TOF-MS) bush tea extract compounds identified before ZnO nanoparticles synthesis using MetFrag software (KEGG and ChemSpider databases, 50 ppm).
Compound name | Formula | RT [sec] | |
---|---|---|---|
1 | (+)-7-Isojasmonic acid | C 12H 18O 3 | 294 |
2 | (6Z,9Z,12Z)-Octadecatrienoic acid | C 18H 30O 2 | 543.6 |
3 | 10-Oxo-11,15-phytodienoic acid | C 18H 28O 3 | 357.6 |
4 | 13-hydroxy-9Z,11E-octadecadienoic acid | C 18H 32O 3 | 652.2 |
5 | 17-Hydroxylinolenic acid | C 18H 30O 3 | 340.8 |
6 | 1-O,6-O-Digalloyl-beta-D-glucose (tannin) | C 20H 20O 14 | 351 |
7 | 3,6-Anhydroglucose | C 6H 10O 5 | 228.6 |
8 | 3-hydroperoxy-4-phenyl-pentan-1-ol/Loliolide | C 11H 16O 3 | 309 |
9 | 3-tert-Butyl-5-methylcatechol | C 11H 16O 2 | 426 |
10 | 4-Heptyloxyphenol | C 13H 20O 2 | 282.6 |
11 | 4”-Hydroxyacetophenone | C 8H 8O 2 | 71.4 |
12 | 4-Hydroxyestradiol-17beta | C 18H 24O 3 | 443.4 |
13 | 5,7,3'-Trimethoxy-6,4',5'-trimethoxyisoflavone | C 18H 16O 8 | 690 |
14 | 7-Hydroxy-2”,4”,5”-trimethoxyisoflavone | C 18H 16O 6 | 726 |
15 | Naringenin 7-O-beta-D-glucoside | C 21H 22O 10 | 435.6 |
16 | 17-Hydroxylinolenic acid | C 18H 30O 3 | 372.6 |
17 | Adenine | C 5H 5N 5 | 783 |
18 | alpha-Curcumene | C 15H 22 | 609.6 |
19 | 5S-Hydroperoxy-18R-HEPE | C 20H 30O 5 | 274.8 |
20 | Atropaldehyde | C 9H 8O | 345 |
21 | Scullcapflavone II | C 19H 18O 8 | 462.6 |
22 | Cinnamaldehyde | C 9H 8O | 354 |
23 | Cisapride | C 29H 27N 3O 3 | 115.8 |
24 | Coumaric acid/Caffeic Aldehyde | C 9H 8O 3 | 285 |
25 | Coumarin | C 9H 6O 2 | 76.8 |
26 | D-Norvaline | C 5H 11NO 2 | 48 |
27 | Homovanillate/Dihydrocaffeic acid | C 9H 10O 4 | 288.6 |
28 | Lancerin | C 19H 18O 10 | 348.6 |
29 | Lophophorine/Stovaine | C 13H 17NO 3 | 55.8 |
30 | Mallotophenone | C 21H 24O 8 | 432 |
31 | Malonyldaidzin | C 24H 22O 12 | 207.6 |
32 | Melampodin A | C 21H 24O 9 | 399.6 |
33 | Montanol | C 21H 36O 4 | 513.6 |
34 | Myrcene/(E)-beta-Ocimene | C 10H 16 | 321.6 |
35 | Nafenopin glucuronide | C 26H 30O 9 | 291 |
36 | Neocnidilide/4-Hexyloxyphenol | C 12H 18O 2 | 421.8 |
37 | Pentalen-13-ol/Nonylphenol | C 15H 24O | 411 |
38 | Petasin/Cafestol | C 20H 28O 3 | 558.6 |
39 | Pinosylvin | C 14H 12O 2 | 276.6 |
40 | Quinestrol | C 25H 32O 2 | 232.2 |
41 | Traumatic acid | C 12H 20O 4 | 403.8 |
42 | Tricin | C 17H 14O 7 | 379.8 |
43 | Umbelliferone/4-Hydroxycoumarin | C 9H 6O 3 | 209.4 |
44 | 4”-Hydroxyacetophenone | C 8H 8O 2 | 1.19 |
Table 2 present the compounds identified from the supernatant after the synthesis of ZnO nanoparticles. The secondary metabolites investigated present a reduced number compared to the ones from the crude extract, thus revealing that a reaction has taken place between bush tea natural extract metabolites and the precursor resulting in the formation of ZnO nanoparticles.
Table 2.
Liquid chromatography quadrupole time-of-flight mass spectrometry (LC-Q-TOF-MS) bush tea extract compounds identified after ZnO nanoparticles synthesis using MetFrag software (KEGG and ChemSpider, 50 ppm).
Compound name | Formula | RT [sec] | |
---|---|---|---|
1 | Indanone | C 9H 8O | 348.6 |
2 | Mallotophenone | C 21H 24O 8 | 432.6 |
3 | Melampodin A | C 21H 24O 9 | 399.6 |
4 | Sterigmatocystin | C 18H 12O 6 | 268.8 |
5 | Umbelliferone | C 9H 6O 3 | 211.8 |
6 | Salicylate | C 7H 6O 3 | 182.4 |
7 | Resolvin E2 | C 20H 30O 4 | 265.8 |
8 | Scullcapflavone II | C 19H 18O 8 | 463.8 |
9 | Myrtenol | C 10H 16O | 306 |
10 | 3-tert-Butyl-5-methylcatechol | C 11H 16O 2 | 427.8 |
11 | (+)-7-Isojasmonic acid | C 12H 18O 3 | 404.4 |
12 | Traumatic acid | C 12H 20O 4 | 91.2 |
13 | 4-Heptyloxyphenol | C 13H 20O 2 | 282.6 |
14 | 4,4”-Dihydroxystilbene | C 14H 12O 2 | 276.6 |
15 | 1,3-Diphenylpropane | C 15H 16 | 309.6 |
16 | Geranyl hydroquinone | C 16H 22O 2 | 781.2 |
17 | Syringin | C 17H 24O 9 | 232.8 |
18 | 3-Hydroxybenzaldehyde | C 7H 6O 2 | 280.2 |
19 | 6-Hydroxyluteolin 7-glucoside | C 21H 20O 12 | 256.2 |
20 | 6-Methoxyaromadendrin 3-O-acetate | C 18H 16O 8 | 388.8 |
21 | Adenine | C 5H 5N 5 | 72.6 |
22 | 9S-hydroxy-10E,12Z,15Z-octadecatrienoic acid | C 18H3 0O 3 | 372.6 |
23 | 9E-Heptadecenoic acid | C 17H 32O 2 | 337.2 |
24 | Carboxymethyloxysuccinate | C 6H 8O 7 | 81 |
25 | Coumarin | C 9H 6O 2 | 219 |
26 | Pent-7alpha-Hydroxykaur-16-en-19-oic acid | C 20H 30O 3 | 319.8 |
27 | Etherolenic acid | C 18H 28O 3 | 357.6 |
28 | Icariin | C 33H 40O 15 | 240 |
In this study, compound identification was carried out using Bruker data analysis and data profiling tools. The KEGG and ChemSpider databases were consulted to find the name and the chemical formula of each identified compound. The different compounds with mass to ratio (m/z) values as well as their retention time (in seconds) were shown with variable importance in the progression (VIP) score plot ( Figure 3). The concentration of eight compounds was found to be high in the crude extract compared to the supernatant after the synthesis of ZnO nanoparticles where their concentrations were low.
Figure 3.
Variable importance in progression (VP) score plot of different compounds found in the bush tea crude extract before synthesis and the supernatant after synthesis of ZnO nanoparticles.
Table 3 present the various compounds
that were involved in the synthesis process of ZnO nanoparticles including five
flavonoids and two polyphenol compounds, as well as one aromatic compound, which
highly reacted with the precursor to form ZnO nanoparticles. Studies have shown
that the synthesis of nanoparticles using plant extracts involves terpenoids,
flavonoids, alkaloids and phenolic acid, which act as reducing, capping, and
stabilizing agents ( Kuppusamy
Table 3.
Identified compounds reported having mostly interacted with the precursor to form ZnO nanoparticles.
Compound name | Formula | Type |
---|---|---|
Naringenin 7-O-beta-D-glucoside | C 21H 22O 10 | Flavonoid |
Scullcapflavone II | C 19H 18O 8 | Flavonoid |
Mallotophenone | C 21H 24O 8 | Polyphenol |
6-Methoxyaromadendrin 3-O-acetate | C 18H 16O 8 | Flavonoid |
2-Phenylacetamide | C 8H 9NO | Polyphenol group |
7-Hydroxy-2”,4”,5”-trimethoxyisoflavone | C 18H 16O 6 | Flavonoid |
Coumarin | C 9H 6O 2 | Aromatic |
Malonyldaidzin | C 24H 22O 12 | Flavonoid |
ZnO nanoparticles characterization
The XRD analysis was done to confirm the crystallinity of the synthesized ZnO
nanoparticles using a Bruker AXS (Germany) D8 advance X-ray diffractometer.
Figure 4 presents the XRD pattern of
the ZnO nanoparticles. The crystallinity of the powder resulting from the
synthesis using
Figure 4.
X-ray diffraction pattern of ZnO nanoparticles.
The PerkinElmer Frontier FTIR spectrometer was used to perform FTIR analyses using Potassium bromide (KBr) (Potassium bromide) optics. The presence of ZnO nanoparticles was confirmed by the peak at 479 cm −1 as shown in Figure 5. The other observed peaks are attributed to the phytochemical components present in the extract solution. The peak at 1113 cm −1 is attributed to the C-O stretching of primary alcohols. The peak at 1427 cm −1 corresponds to the O-H bending of the carboxylic acid. The peak observed at 2351 cm −1 is attributed to the O=C=O stretching of carbon dioxide. The FTIR spectra of bush tea extract, presented in Figure 6, show the presence of carboxylic acid bonding, primary alcohol stretching as well as the intramolecular hydrogen bond.
Figure 5.
Fourier-transform infrared spectra of ZnO powder annealed at 600°C.
Figure 6.
Fourier-transform infrared spectra of Bush tea leaf extract.
UV-Vis analyses were performed at a resolution of 1 nm at a 250–800 nm
wavelength range using a PerkinElmer Lambda 650S UV-Vis spectrometer. The
absorption of ZnO nanoparticles is observed in the wavelength range of
250–400 nm ( Kolekar
Figure 7.
Ultraviolet-visible spectra of as-synthesized ZnO nanoparticles.
A JEOL JSM-7500F field-emission scanning electron microscope (FE-SEM) coupled
with a JXA-8230/SXEDS/EDS/WDS energy-dispersive X-ray spectrometer (EDS) was
used to get the morphology and the purity of the ZnO nanoparticles. SEM results
are represented in Figure 8. The image
shows quasi-spherical shaped ZnO nanoparticles agglomerated together. The EDS
confirmed the presence of Zn and O. These findings are supported by Nethavhanani (2017) using natural
extracts of
Figure 8.
(a) Scanning electron microscopy image and (b) Energy-dispersive X-ray spectra of ZnO nanoparticles.
Discussion
Understanding the process of nanoparticle synthesis using the green route is key to
the efficiency of the process and the outcome. Following the lack of data on
chemical interactions of plant extracts with different metals to form nanoparticles,
this study aimed to investigate the interaction of compounds with zinc nitrate to
form ZnO nanoparticles. The identification of plant metabolites was performed using
LC-MS tools employing different databases such as KEGG, ChemSpider or Metfrag (
Cecilia
Conclusion
In this study, bush tea metabolites were screened to understand their interaction with metal ions to form nanoparticles. The LC-MMS peaks in both the crude extract before ZnO nanoparticles synthesis and the supernatant after synthesis revealed a significant difference, shown by the PCAs. Different flavonoids, polyphenols and an aromatic compound were found to react with zinc nitrate to form zinc nanoparticles. The FTIR as well as the XRD and UV-Vis analyses confirmed the formation of ZnO nanoparticles with a hexagonal wurtzite structure.
Data availability
All data underlying the results are available as part of the article and no additional source data are required.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright: © 2022 Kaningini GA et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background: Nanoparticles are globally synthesized for their
antimicrobial, anti-inflammatory, wound healing, catalytic, magnetic, optical,
and electronic properties that have put them at the forefront of a wide variety
of studies. Among them, zinc oxide (ZnO) has
received much consideration due to its technological and medicinal
applications. In this study, we report on the synthesis process
of ZnO nanoparticles using
Methods: Liquid chromatography–mass spectrometry (LC-MS) was used to identify the compounds responsible for the synthesis of ZnO nanoparticles. Structural, morphological and optical properties of the synthesized nanoparticles have been characterized through X-ray diffraction (XRD), Ultraviolet-visible spectroscopy (UV-Vis), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS).
Results: LC-MS results showed that different flavonoids and polyphenols, as well as Coumarin, an aromatic compound, reacted with the precursor to form ZnO nanoparticles. XRD and UV-Vis analysis confirmed the synthesis of ZnO nanoparticles, with a spherical shape showed in SEM images. The quasi-spherical ZnO crystals had an average crystallite size of 24 nm. EDS and FTIR analysis confirmed that the powders were pure with no other phase or impurity.
Conclusions: This study successfully demonstrated that the
natural plant extract of
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer